Eric Brandt, Investment Manager at NOSHAQ, will replace Jean-Claude Muller at the next Op2Lysis Board meeting. Jean-Claude has decided to leave the governance of Op2Lysis and that of other companies for personal reasons. NOSHAQ’s support during the last Op2Lysis fundraiser has been a driving component of our funding to get closer to the initiation stage of clinical trials. Eric’s professional career during more than 12 years, in the financing of companies in the field of life sciences, will constitute a definite contribution to the Company, and in complementarity with the other members. The integration of Eric in the governance of Op2Lysis testifies to the expansion of Op2Lysis in the ecosystem of Wallonia to structure its development activities, while keeping its research activity in Caen in Normandy.
We welcome Eric to this new role. We warmly thank Jean-Claude for his essential and significant contribution since the creation of Op2Lysis.
The 6 members of the Board of Op2Lysis are now: Eric Brandt, Patrick Cassagne, Christophe Gaudin, Philippe Monteyne, Jérôme Parcq and Thierry Sempere.